MATEON THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT February 14, 2020Warrant Agreement • June 29th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Mateon Therapeutics, Inc., a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below) by the Company in accordance with the terms of the Warrant Purchase Agreement between the Company and the Holder dated as of February __, 2020 pursuant to which Warrant the Holder ha the right to purchase shares of the Company’s Common Stock, $0.01 par value per share (the “Common Stock”) as set forth herein.
